ROSEN, TRUSTED INVESTOR COUNSEL, Encourages XL Fleet Corp. Investors to Secure Counsel Before Important May 7 Deadline in Securities Class Action – XL
May 01, 2021 10:30 ET
|
The Rosen Law Firm PA
NEW YORK, May 01, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of XL Fleet Corp. (NYSE: XL) between October 2, 2020 and March...
Josip Heit, GStelecom, G999 and GSmedia, or the questions about the potential of blockchain for private users
May 01, 2021 10:02 ET
|
GSB GOLD STANDARD BANKING CORPORATION AG
HAMBURG, Germany, May 01, 2021 (GLOBE NEWSWIRE) -- G999 Blockchain technology, a spam-hacker-free email service, a voice & chat system in compliance with environmental regulations and a current...
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Plug Power Inc. Investors to Secure Counsel Before Important May 7 Deadline in Securities Class Action – PLUG
May 01, 2021 10:00 ET
|
The Rosen Law Firm PA
NEW YORK, May 01, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Plug Power Inc. (NASDAQ: PLUG) between November 9, 2020...
FINAL DEADLINE ALERT: ROSEN, A LEADING LAW FIRM, Encourages Athenex, Inc. Investors With Losses over $100K to Secure Counsel Before Important Monday Deadline in Securities Class Action – ATNX
May 01, 2021 09:30 ET
|
The Rosen Law Firm PA
NEW YORK, May 01, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Athenex, Inc. (NASDAQ: ATNX) between August 7, 2019 and...
FINAL DEADLINE ALERT: ROSEN, A LEADING LAW FIRM, Encourages Renewable Energy Group, Inc. Investors with Losses over $100K to Secure Counsel Before Important Monday Deadline in Securities Class Action – REGI
May 01, 2021 09:00 ET
|
The Rosen Law Firm PA
NEW YORK, May 01, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Renewable Energy Group, Inc. (NASDAQ: REGI) between May 3,...
Denali Therapeutics Presents Positive Results from Phase 1 and Phase 1b Studies of Its LRRK2 Inhibitor, BIIB122/DNL151, Supporting Late-Stage Development Plans in Parkinson’s Disease
May 01, 2021 09:00 ET
|
Denali Therapeutics Inc.
Treatment with BIIB122/DNL151 achieved robust reductions in biomarkers of target engagement and pathway engagement in healthy volunteers and patients with Parkinson’s diseaseBIIB122/DNL151...
HiPay: Availability of the Annual Report
May 01, 2021 08:37 ET
|
HiPay Group
HiPay: Availability of the Annual Report Paris, April 30, 2021: HiPay (ISIN code FR0012821916 – HIPAY), the fintech specialized in Omnichannel payment solutions, announces the availability of its...
Oyster Point Pharma Announces Clinical Data Presentation of OC-01 (varenicline) Nasal Spray for Dry Eye Disease at the Association for Research in Vision and Ophthalmology 2021 Virtual Annual Meeting
May 01, 2021 08:00 ET
|
Oyster Point Pharma, Inc.
PRINCETON, N.J., May 01, 2021 (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc. (Nasdaq: OYST), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of...
Editas Medicine to Present Preclinical Data Demonstrating Advancements in In Vivo Gene Editing Approach for the Treatment of Genetic Ocular Diseases at the Association for Research in Vision and Ophthalmology Annual Meeting
May 01, 2021 07:11 ET
|
Editas Medicine, Inc.
CAMBRIDGE, Mass., May 01, 2021 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced that two scientific abstracts have been accepted for...
Novartis Phase III Beovu® data show potential for fluid resolution in more diabetic macular edema patients with fewer injections versus aflibercept
May 01, 2021 07:05 ET
|
Novartis Pharma AG
In KESTREL and KITE, Beovu (brolucizumab) 6 mg met the primary endpoints of non-inferiority in change in best corrected visual acuity from baseline versus aflibercept 2 mg at year one in diabetic...